n-methylaspartate has been researched along with Adenoma Sebaceum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alami, M; Brion, JD; Chiron, C; Dossi, E; Dulac, O; Galvani, G; Gataullina, S; Huberfeld, G; Laschet, J; Lemaire, É; Messaoudi, S; Nous, C; Touchet, S | 1 |
| Foutz, TJ; Friedman, JL; Galindo, R; Johnson, KJ; Rensing, N; Wong, M | 1 |
2 other study(ies) available for n-methylaspartate and Adenoma Sebaceum
| Article | Year |
|---|---|
GluN2C selective inhibition is a target to develop new antiepileptic compounds.
Topics: Animals; Anticonvulsants; Epilepsy; Humans; Infant; Mice; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Seizures; Tuberous Sclerosis | 2022 |
Early developmental electroencephalography abnormalities, neonatal seizures, and induced spasms in a mouse model of tuberous sclerosis complex.
Topics: Animals; Animals, Newborn; Arousal; Disease Models, Animal; Electroencephalography; Electromyography; Female; Male; Mice; Mice, Inbred C57BL; N-Methylaspartate; Seizures; Tuberous Sclerosis | 2020 |